Jupiter Neurosciences, Inc. (JUNS) Stock Statistics & Valuation Metrics

Jupiter Neurosciences, Inc. has a market cap or net worth of $37.87M. The enterprise value is ―.

Jupiter Neurosciences, Inc. has 34,426,353 shares outstanding. The number of shares has decreased by -2.65% in one year.

Jupiter Neurosciences, Inc.’s return on equity (ROE) is -0.58 and return on invested capital (ROIC) is -70.42%.

The current PE Ratio of Jupiter Neurosciences, Inc. is ―. Jupiter Neurosciences, Inc.’s PEG ratio is 3.20.

In the last 12 months, Jupiter Neurosciences, Inc. had revenue of 0.00 and earned -2.44M in profits. Earnings per share was -0.08.

In the last 12 months, operating cash flow was -6.74M and capital expenditures 0.00, giving a free cash flow of -6.74M billion.

Jupiter Neurosciences, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―

Jupiter Neurosciences, Inc. upcoming earnings date is ―, ―.

Jupiter Neurosciences, Inc. as a current ratio of 2.31, with Debt / Equity ratio of 314.18%

In the past 12 months, Jupiter Neurosciences, Inc. has paid 0.00 in taxes.

Jupiter Neurosciences, Inc. EV to EBITDA ratio is -138.93, with an EV/FCF ratio of -77.84.

Jupiter Neurosciences, Inc. has $723.80K in cash and marketable securities with $180.39K in debt, giving a net cash position of $543.40K billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Jupiter Neurosciences, Inc. is $25.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy